Form 4: W. P. Carey Director Robert Flanagan Receives Annual Restricted Share Award
SEC Form 4 Filing
Director Robert J. Flanagan received an annual award of restricted shares in W. P. Carey Inc. on July 1, 2024.
Summary
- Robert J. Flanagan, a director of W. P. Carey Inc., filed a Form 4 on July 1, 2024, reporting a transaction.
- The transaction involved the acquisition of 3,203 shares of common stock as an annual award of restricted shares.
- These shares were granted under the company's Amended and Restated 2017 Share Incentive Plan.
- The restricted shares are scheduled to vest in full on the anniversary of the grant date.
- The underlying shares will be paid at the end of the deferral period selected by Flanagan under the company's Deferred Compensation Plan for Non-Employee Directors.
- Following the transaction, Flanagan beneficially owns 16,713 shares of W. P. Carey Inc. common stock.
Sentiment
Score: 7
Explanation: The document reflects a routine transaction related to director compensation, which is generally viewed neutrally to positively as it aligns interests. There are no indications of negative sentiment.
Positives
- The grant of restricted shares aligns the director's interests with those of the shareholders.
- The vesting schedule encourages long-term commitment from the director.
Future Outlook
The restricted shares will vest in the future, aligning the director's interests with the company's long-term performance.
Industry Context
The granting of restricted stock is a common practice in corporate governance to incentivize directors and align their interests with shareholders.
Comparison to Industry Standards
- Many REITs and publicly traded companies use restricted stock grants as part of their compensation packages for directors and executives.
- Companies like Boston Properties (BXP) and Simon Property Group (SPG) also utilize similar share incentive plans to align management and shareholder interests.
- The specific number of shares granted and the vesting schedule can vary based on company size, performance, and industry benchmarks.
Stakeholder Impact
- Shareholders may view the granting of restricted stock positively as it aligns the director's interests with the company's performance.
- The director benefits from the potential future value of the shares.
Key Dates
| Date | Description |
|---|---|
| 2023/09/13 | Date of Power of Attorney execution. |
| 2024/07/01 | Date of the transaction: Robert J. Flanagan acquired 3,203 shares of common stock. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.